cAMP analogs reflected stimulation of PKA-mediated
). The second intracellular ing the PKA inhibitor Rp-cAMPS (data not shown). These data suggest that VR1 can be maintained in a sensitized loop was omitted since it does not contain any serines or threonines. All of the engineered proteins acted as functional state and/or rescued from desensitization by PKA-mediated phosphorylation.
in vitro substrates for PKA with saturating time courses ( Figures 2C-2E ). Since PKA activation modulates VR1 function, we wanted to determine whether VR1 was directly phosWe utilized classic HPLC and Edman based techniques as well as ESI mass spectroscopy to delineate phorylated by PKA. VR1, immunoprecipitated from 32 P-labeled, VR1-transfected cells, displayed high levels PKA in vitro phosphorylation sites located on the engineered cytoplasmic domains. In-gel digest with Lys-C of basal 32 P incorporation ( Figure 1C) . Surprisingly, 8Br-cAMP had little effect on basal phosphorylation (Figures followed by HPLC of the N-terminal protein revealed three major radioactive phosphopeptide peaks ( Figure  1C and 1D ). This may indicate that PKA does not phosphorylate VR1, that basal VR1 phosphorylation saturates 3A). Sequencing of these fractions coupled with scintillation counting of the sequencing cycles revealed PKA sites on VR1, or that PKA phosphorylation may only become significantly obvious in the desensitized Thr144, Thr370, and Ser6 as phosphorylation sites (Figures 3B-3D ). However, significant radioactivity restate. Since our physiology experiments suggested that PKA attenuates VR1 desensitization, we pursued the mained on the sequencing filter from peak 2, indicating the major phosphorylation site in this HPLC fraction was last possibility and examined VR1 phosphorylation after yet to be reached and that Ser6 is an extremely minor may indicate that Ser6, Thr144, and Thr370 are the only phosphorylation sites. ESI mass spectroscopy, although site ( Figure 3C ). This phosphorylation site may exist farther along in the same peptide or possibly in a low sensitive, can fail to identify large phosphopeptides that fall outside the dynamic range of the Ϫ79 precursor abundance, coeluting peptide. In an attempt to obtain smaller peptides for phosphorylation site identification, scan window. Presumably, this was the case with Ser6, which resides in a predicted tryptic peptide of 40 resiwe conducted an in-gel trypsin digest followed by ESI mass spectroscopy, but only found Thr144 and Thr370 dues. Furthermore, a mutant N-terminal fusion protein with Ser6, Thr144, and Thr370 altered to alanines exhibas phosphorylation sites (data not shown). These data Figure 3G ). Considering these findings, we hypothesized that a major phosphorylation site remained unlated and dephosphorylated states of the VR1 protein, respectively. Using this hypothesis as a guide, we identified.
We pursued the putative missing site by conducting sought to elucidate the functional roles of the biochemically determined PKA phosphorylation sites in the native an Asp-N in-gel digest of a mutant N-terminal protein with Ser6, Thr144, and Thr370 altered to alanines. Ceren-VR1 protein. Initially, inactivating or "constitutively dephosphorylated" alanine mutations were created in each kov counting of the HPLC fractions yielded a highly of the key serine and threonine residues and capsaicin phosphorylated peptide (Figure 3E) , which upon seresponses of cells transiently expressing each mutant quencing revealed Ser116 as the phosphorylation site determined by electrophysiology. Based on our starting ( Figure 3F ). Although HPLC fraction radioactivity is not hypothesis, we expected two possible results. One posequivalent to stoichiometry due to variation in gel elusibility was that the dephosphorylated mutant is equivtion, the Ser116 phosphopeptide radioactivity peak is alent to or reproduces the desensitized state. This about one order of magnitude larger than the previous hypothesis predicts small currents, which fail to desenpeaks attributed to Thr144 or Thr370, suggesting Ser116 sitize any further. Another possibility was that dephosmay be the major N-terminal phosphorylation site. Inphorylation enhances the rate of entry or decreases the deed, PKA phosphorylation of the single Ser116Ala murate of exit from desensitized states. In this case, a tant fusion protein was almost 70% less than wild-type dephosphorylated mutant may show normal currents ( Figure 3G ).
with exaggerated desensitization. The first intracellular loop contains two potential PKA Both current density (pA/pF) of the initial capsaicin phosphorylation sites, Ser502 and Ser505, based simply response and the degree of desensitization for the secon proximity to positively charged residues. In order to ond of two consecutive capsaicin applications were asdifferentiate these sites, phosphorylated peptide was sessed for wild-type, S6A, S116A, T144A, T370A, S502A, sequenced by Edman degradation, and scintillation S774A, and S820A mutants. Desensitization was significounting of the cycles clearly delineated Ser502 as the cantly altered in several mutants ( Figure 4A ). S774A and PKA phosphorylation site ( Figure 3H ). S820 appeared to follow one prediction with enhanced Phosphorylation sites on the C-terminal intracellular desensitization, while T144A fit the other prediction, exdomain protein were identified using ESI mass spectroshibiting little desensitization. However, desensitization copy. Peptides from an in-gel trypsin digest of the phosseemed to be related to initial current density, such that phorylated C-terminal protein were subjected to a Ϫ79 mutants with lower current densities desensitized less precursor ion scan, which delineated two major phosthan mutants with large current densities ( . Thus, the apparent differences in desensitiand possibly Ser6 as minor sites. Ser502 requires apzation amongst the inactivating mutants probably reflect proximately 50-to 100-fold less kinase to achieve satudifferences in current density rather than phosphorylarating phosphorylation, while Ser116 accounts for the tion-mediated changes in desensitization. Indeed, when largest single site stoichiometry ‫.)%53ف(‬ mutant desensitization is plotted against current density, the mutants lie along the regression line determined Functional Characterization of PKA for wild-type VR1 ( Figure 4D ).
Phosphorylation Site Mutants
We hypothesized that differences in current density Given the functional evidence that PKA-mediated phossimply reflected changes in surface expression, thereby phorylation can rescue VR1 from agonist-induced decorrespondingly changing VR1-mediated calcium influx. sensitization ( Figure 1B type, T144A, and T144D VR1 receptors. The T144 mu-PKA-Dependent Sensitization of VR1 Requires Ser116 tants exhibit varying degrees of current amplitude deficits measured as decreased current density ( Figure 4B) Since none of the inactivating mutants exhibited phosphorylation-based changes in desensitization, we hyand reduced proportion of cells responding to 1 M capsaicin (29/29 for wild-type VR1, 13/34 for T144A, and pothesized that PKA phosphorylation of VR1 may prevent desensitization, while dephosphorylation at a 6/13 for T144D) or pH 5 (15/15 for wild-type, 3/12 for T144A, and 6/10 for T144D). Correlating well to current particular site may simply be permissive to desensitization. Using this rationale, we constructed aspartate mudensity, T144A showed heavily reduced surface expression, while T144D exhibited moderately diminished surtants, which mimic a "constitutively phosphorylated" state, and hypothesized that a functionally relevant site face expression compared to wild-type (Figures 4E and  4F ). Pilot studies with S6A, T370A, S502A, and S820A would exhibit little desensitization. We returned to results from the in vitro biochemistry and focused our showed similar results with surface expression varying between 60% and 130% compared to wild-type (data attention on aspartate mutants at the qualitatively significant phosphorylation sites of Ser116 and Ser502. not shown). We again assessed the degree of desensitization by vents normal desensitization of wild-type VR1, it completely fails to alter desensitization of the S116A mutant comparing the second of two responses to capsaicin to the initial response for cells transiently transfected ( Figures 5C and 5D ). Conversely, 8Br-cAMP treatment dramatically inhibits desensitization in all of the other with S116D and S502D. While S502D desensitization was indistinguishable from wild-type, S116D exhibited desensitizing mutants, including the high current density, heavily desensitizing S774A and S820A mutants strongly blunted desensitization, mimicking wild-type VR1 after 8Br-cAMP treatment (Figures 5A and 5C ).
( Figure 5D ). Taken together, these data strongly support an exclusive role for Ser116 in PKA-mediated regulation Again, reduced desensitization of S116D may simply reflect lower current density. However, when plotted on of VR1 sensitivity to capsaicin. Given that desensitization and its regulation may be the regression curve describing the relationship between desensitization and current density (see Figure  ligand specific, we wanted to verify that our results were generally applicable to other ligands such as protons, 4), S116D shows a significant deviation from wild-type ( Figure 5B While we can confidently attribute Ser116 phosphoryla-
In Vitro Phosphorylation of Fusion Proteins
Surface Biotinylation Assay CHO-K1 cells expressing wild-type or mutant VR1 were grown in and Synthetic Peptide Phosphorylation reactions consisted of 100 M peptide or 1.8 M 35 mM dishes, rinsed in PBS, and incubated with NHS-SS-biotin (Pierce, 1.5 mg/ml) for 1 hr at 4ЊC. The biotinylation reaction was fusion protein ‫1.0ف(‬ mg/mL), 50 mM Tris-Cl (pH 7.5), 1 mM EDTA (pH 8), 12 mM Mg-acetate, 0.25 mM ATP, 1 Ci/L ␥-32 P-ATP quenched with 100 mM glycine in PBS, then the cells were washed, lysed in RIPA buffer, and centrifuged (20,000 ϫ g) for 30 min. The ‫0008-0004ف(‬ cpm/pmol ATP), and 0.01 U/l (peptide) or 1 U/l (fusion proteins) bovine heart protein kinase A catalytic subunit supernatant was removed and incubated with streptavidin beads (Sigma, St. Louis, MO) for 1 hr at room temperature. The beads were (Sigma, St. Louis, MO), and were incubated at 30ЊC. Reactions were stopped at various time points by spotting onto P81 phosphocelluthen spun down to separate proteins associated with the surface membrane from those in the cytosol or intracellular vesicles (superlose paper (peptide) or by adding an equal volume of 2ϫ sample buffer and boiling for 5 min (fusion proteins). P81 squares with natant). After washing the beads three times in RIPA buffer, biotinylated proteins were eluted with sample buffer and both supernatant blotted peptides were washed several times in 75 mM phosphoric acid, dried with methanol, and placed into 10 ml scintillation fluid. and eluted proteins were subjected to SDS-PAGE and Western blot with a VR1 N-terminal antibody. Fusion proteins were electrophoresed on SDS-PAGE gels, stained with Coommassie blue, and quantified using nearby BSA standards. 32 P incorporation was quantified using scintillation counting of blotAcknowledgments ted peptides or phosphorimaging and densitometry of fusion protein bands (Packard Instruments, Meridian, CT).
We would like to thank Dr. Richard Cook and the Baylor College of Initial reactions with and without 0.04 U/l PKA were incubated Medicine Protein Sequencing Core Facility for assistance with Edfor 30 min to determine whether peptide or fusion proteins were in man sequencing and mass spectroscopy. We would also like to vitro substrates (data not shown). Subsequent preliminary experithank Sheetal Mehta for assistance with tissue culture. We acknowlments focused on obtaining optimal phosphorylation reaction con- 
